Stanley Jacot Jr - Feb 2, 2022 Form 4 Insider Report for Arcadia Biosciences, Inc. (RKDA)

Role
Chief Executive Officer
Signature
Stanley Jacot, by Attorney-in-Fact, Cesare Suardi
Stock symbol
RKDA
Transactions as of
Feb 2, 2022
Transactions value $
$0
Form type
4
Date filed
2/4/2022, 01:01 PM
Next filing
Apr 28, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RKDA Stock Option (right to buy) Award $0 +316K $0.00 316K Feb 2, 2022 Common Stock 316K $0.91 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% of the total number of shares subject to the Option will vest on the first anniversary of the date of the award; the remaining 75% will vest in 36 equal installments, subject to the Participant's continued service.